Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | TLR4 | O00206 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL940890 | 0.94 | L3MBTL1 (0.45) | L3MBTL1HSD17B10TLR4POLBALDH1A1 | |
| SCHEMBL3193620 | 0.90 | L3MBTL1 (0.42) | L3MBTL1HSD17B10TLR4POLBALDH1A1 | |
| SCHEMBL8826699 | 0.90 | FKBP5 (0.43) | L3MBTL1HSD17B10TLR4POLBALDH1A1 | |
| SCHEMBL907623 | 0.90 | MAPT (0.45) | HSD17B10TLR4POLBALDH1A1MAPT | |
| SCHEMBL27405623 | 0.90 | MAPT (0.45) | HSD17B10TLR4POLBALDH1A1MAPT | |
| SCHEMBL20553752 | 0.87 | HSD17B10 (0.57) | L3MBTL1HSD17B10POLBALDH1A1MEN1 | |
| SCHEMBL24878938 | 0.83 | L3MBTL1 (0.42) | L3MBTL1HSD17B10TLR4POLBALDH1A1 | |
| SCHEMBL2789189 | 0.81 | L3MBTL1 (0.54) | L3MBTL1HSD17B10POLBALDH1A1MEN1 | |
| SCHEMBL14094291 | 0.80 | HSD17B10 (0.46) | L3MBTL1HSD17B10POLBALDH1A1MEN1 | |
| SCHEMBL14094109 | 0.79 | CCR2 (0.45) | L3MBTL1HSD17B10POLBALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108484484-B | Preparation method of 2-oxo-3-ethyl piperidinecarboxylate | 上海泾维化工科技有限公司 | 2021-01-05 | — | — | CN | claimed |
| US-20180326407-A1 | Olefin polymerization catalyst components and process for the production of olefin polymers therewith | FORMOSA PLASTICS CORPORATION, USA | 2018-11-15 | — | — | US | claimed |
| US-10124324-B1 | Olefin polymerization catalyst components and process for the production of olefin polymers therewith | FORMOSA PLASTICS CORPORATION, USA (US) | 2018-11-13 | — | — | US | claimed |
| EP-2262845-A1 | MONOMERS AND POLYMERS WITH COVALENTLY-ATTACHED ACTIVE INGREDIENTS | University of Southern Mississippi (US) | 2010-12-22 | — | — | EP | claimed |
| US-20100163070-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBRES USING HEATING MEANS AND AN AMIDE | L'OREAL S.A. (FR) | 2010-07-01 | — | — | US | claimed |
| US-20090208553-A1 | Monomers and Polymers with Covalently - Attached Active Ingredients | UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2009-08-20 | — | — | US | claimed |
| WO-2009102795-A1 | MONOMERS AND POLYMERS WITH COVALENTLY-ATTACHED ACTIVE INGREDIENTS | UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2009-08-20 | — | — | WO | claimed |
| EP-0552360-A1 | A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE | THE DOW CHEMICAL COMPANY (US) | 1993-07-28 | — | — | EP | claimed |
| WO-1993003825-A1 | A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE | THE DOW CHEMICAL COMPANY (US) | 1993-03-04 | — | — | WO | claimed |
| US-5167941-A | Sulfur dioxide; cationic polyelectrolyte stabilizers | THE DOW CHEMICAL COMPANY (US) | 1992-12-01 | — | — | US | claimed |
| US-12637680-B2 | Recombinant host cells for the production of malonate | LYGOS, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| EP-4741397-A1 | FUSED TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shenzhen Zhongge Biological Technology Co., Ltd. (CN) | 2026-05-13 | — | — | EP | disclosed |
| EP-4629980-A1 | ANTIMICROBIAL COMPOUNDS | SRI International (US) | 2025-10-15 | — | — | EP | disclosed |
| US-12421232-B2 | Kinase inhibitor compounds and compositions and methods of use | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2025-09-23 | — | — | US | disclosed |
| US-12371429-B2 | Antibiotic resistance-modifying tricyclic heteroaryl compounds and uses thereof | RECREO PHARMACEUTICALS LLC (US) | 2025-07-29 | — | — | US | disclosed |
| WO-1993024519-A1 | LACTAM DIPEPTIDES HAVING HLE INHIBITING ACTIVITY | ZENECA LIMITED (GB) | 1993-12-09 | — | — | WO | disclosed |
| EP-0552360-A1 | A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE | THE DOW CHEMICAL COMPANY (US) | 1993-07-28 | — | — | EP | disclosed |
| WO-1993003825-A1 | A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE | THE DOW CHEMICAL COMPANY (US) | 1993-03-04 | — | — | WO | disclosed |
| US-5167941-A | Sulfur dioxide; cationic polyelectrolyte stabilizers | THE DOW CHEMICAL COMPANY (US) | 1992-12-01 | — | — | US | disclosed |
| US-3987183-A | TRANSFERASE INHIBITOR, TREATMENT OF MENTAL ABERRATIONS AS SCHIZOPHRENIA | MERCK & CO., INC. (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12371429-B2 | Antibiotic resistance-modifying tricyclic heteroaryl compounds and uses thereof | CBR3, CBR1, CYP2B6 | L3MBTL1 1925/4885HSD17B10 928/4885TLR4 3751/4885 |
| US-12421232-B2 | Kinase inhibitor compounds and compositions and methods of use | CSNK1A1, DYRK1A, CSNK1G3 | L3MBTL1 3307/4885HSD17B10 2393/4885TLR4 4741/4885 |
| US-12637680-B2 | Recombinant host cells for the production of malonate | DCXR, ETV1, LYPLA2 | L3MBTL1 236/4885HSD17B10 155/4885TLR4 936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.